601.75
-1.38%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in INR, from our data supplier.
Revenue
₹40.73bn
FY2016FY2025
Net income
−₹651.2m
FY2016FY2025
Free cash flow
₹557.3m
FY2016FY2025
Shareholders' equity
₹56.70bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹40.73bn | ₹38.07bn | ₹45.17bn | ₹37.59bn | ₹24.29bn | ₹27.25bn | ₹31.61bn | ₹25.14bn | ₹23.03bn | ₹22.18bn |
| Gross profit | ₹11.02bn | ₹8.13bn | ₹17.64bn | ₹16.10bn | ₹8.87bn | ₹11.00bn | ₹15.80bn | ₹11.92bn | ₹8.44bn | ₹6.84bn |
| Research and development | — | — | — | — | — | ₹12.3m | ₹10.2m | ₹7.6m | ₹11.2m | — |
| Operating income | −₹216.7m | −₹2.34bn | ₹8.39bn | ₹7.89bn | ₹1.84bn | ₹4.23bn | ₹9.79bn | ₹6.60bn | ₹3.39bn | ₹2.28bn |
| Net income | −₹651.2m | −₹2.37bn | ₹4.10bn | ₹5.60bn | ₹1.66bn | ₹3.32bn | ₹6.90bn | ₹5.34bn | ₹3.07bn | ₹2.20bn |
| Diluted earnings per share | -8.87 | -32.27 | 55.78 | 76.22 | 22.57 | 45.29 | 93.95 | 72.80 | 41.86 | 29.89 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ₹79.87bn | ₹80.23bn | ₹83.35bn | ₹79.77bn | ₹71.57bn | ₹58.91bn | ₹55.31bn | ₹49.70bn | ₹44.35bn | ₹38.94bn |
| Cash and short-term investments | ₹1.45bn | ₹1.75bn | ₹4.97bn | ₹3.20bn | ₹4.07bn | ₹430.1m | ₹2.71bn | ₹1.35bn | ₹1.67bn | — |
| Total liabilities | ₹23.17bn | ₹19.48bn | ₹21.96bn | ₹20.78bn | ₹17.80bn | ₹12.95bn | ₹12.35bn | ₹11.49bn | ₹10.80bn | ₹9.66bn |
| Debt | ₹4.42bn | ₹4.18bn | ₹4.60bn | ₹5.50bn | ₹4.34bn | ₹1.39bn | ₹1.88bn | ₹2.34bn | ₹6.38bn | ₹5.18bn |
| Shareholders' equity | ₹56.70bn | ₹60.76bn | ₹61.39bn | ₹58.99bn | ₹53.78bn | ₹45.96bn | ₹42.96bn | ₹38.21bn | ₹33.56bn | ₹29.28bn |
| Shares outstanding | 73m | 73m | 73m | 73m | 73m | 73m | 73m | 73m | 73m | 73m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₹3.81bn | ₹666.2m | ₹9.60bn | ₹7.35bn | ₹4.21bn | ₹6.30bn | ₹8.38bn | ₹5.14bn | ₹5.02bn | ₹2.01bn |
| Capital spending | −₹3.25bn | −₹2.31bn | −₹6.83bn | −₹9.09bn | −₹7.94bn | −₹5.74bn | −₹3.86bn | −₹2.85bn | −₹4.36bn | −₹2.81bn |
| Free cash flow | ₹557.3m | −₹1.65bn | ₹2.77bn | −₹1.74bn | −₹3.73bn | ₹559.5m | ₹4.52bn | ₹2.29bn | ₹660.2m | −₹804.6m |
| Dividends paid | −₹1.02bn | −₹1.73bn | −₹735.9m | −₹588.9m | −₹588.8m | −₹709.8m | −₹576.3m | −₹444.0m | −₹398.4m | −₹398.7m |
Latest quarters
By quarter end
| Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹10.44bn | ₹10.83bn | ₹11.05bn | ₹10.75bn | ₹10.29bn | ₹9.91bn | ₹9.77bn | ₹10.02bn |
| Gross profit | ₹3.31bn | ₹3.46bn | ₹3.70bn | ₹3.50bn | ₹3.26bn | ₹2.90bn | ₹2.71bn | ₹2.43bn |
| Operating income | ₹6.3m | −₹300.4m | ₹147.5m | ₹165.2m | −₹2.7m | −₹252.3m | −₹228.9m | −₹678.7m |
| Net income | −₹199.5m | ₹163.4m | −₹137.8m | ₹88.2m | −₹112.3m | −₹181.8m | −₹445.3m | −₹461.9m |
| Diluted earnings per share | -2.72 | 2.23 | -1.88 | 1.20 | -1.53 | -2.48 | -6.06 | -6.29 |
| Cash from operations | — | ₹2.98bn | — | ₹3.81bn | — | ₹1.70bn | — | ₹666.0m |
| Capital spending | — | −₹1.38bn | — | −₹3.25bn | — | −₹1.23bn | — | −₹2.31bn |
| Free cash flow | — | ₹1.60bn | — | ₹557.0m | — | ₹468.0m | — | −₹1.65bn |
| Total assets | — | ₹82.09bn | — | ₹79.87bn | — | ₹84.13bn | — | ₹80.23bn |
| Cash and short-term investments | — | ₹4.43bn | — | ₹2.04bn | — | ₹3.45bn | — | ₹2.05bn |
| Debt | — | ₹2.64bn | — | ₹3.17bn | — | ₹2.88bn | — | ₹3.43bn |
| Shareholders' equity | — | ₹55.70bn | — | ₹56.70bn | — | ₹61.86bn | — | ₹60.76bn |
Financial ratios
Data as of 20 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 13.8% | 30.4% | 16.4% | 66.6% | 61.8% | 55.5% |
| Operating margin | 1.9% | 21.3% | -6.8% | 19.2% | 22.6% | 10.6% |
| Net margin | -0.1% | -1.6% | -6.3% | 9.1% | 15.2% | 7.0% |
| Return on equity | -0.0% | -1.1% | -3.9% | 6.7% | 9.5% | 3.1% |
| Return on assets | -0.0% | -0.8% | -3.0% | 4.9% | 7.0% | 2.3% |
| Free cash flow yield | 14.2% | 15.1% | 6.4% | 35.0% | 35.0% | 25.9% |
| Revenue growth | 7.0% | 7.8% | -16.3% | 22.3% | 57.0% | -13.2% |
| Earnings growth | -96.3% | -72.5% | -157.8% | -26.8% | 237.7% | -50.1% |
| Current ratio | 1.19x | 1.13x | 1.23x | 1.68x | 1.49x | 1.78x |
| Debt to equity | 0.11x | 0.09x | 0.09x | 0.10x | 0.10x | 0.09x |
| Equity ratio | 68.9% | 72.2% | 75.7% | 73.7% | 73.9% | 75.1% |
| Interest coverage | 1.33x | 17.16x | -6.03x | 48.34x | 174.60x | 17.70x |
| R&D as a share of sales | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.1% |
| Buybacks as a share of market value | 0.0% | -0.1% | 0.1% | 0.0% | 0.0% | -0.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.7% | 8.4% | 7.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 24.3% | 32.7% | 34.1% | 38.3% |
| Operating margin | -3.2% | 8.5% | 9.3% | 13.0% |
| Net margin | -3.8% | 4.1% | 5.5% | 9.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -56.9 | -23.4 | 13.9 | 10.1 | 28.9 | 7.8 | 4.4 | 7.5 | 18.3 | 11.6 |
| Price to sales | 0.9 | 1.4 | 1.3 | 1.5 | 2.0 | 0.9 | 1.0 | 1.6 | 2.4 | 1.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 22 years. Last went ex-dividend on 18 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 15.80 | 13.85 | 23.55 | 10.00 | 8.00 | 8.00 | 8.00 | 6.50 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.